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Background
A vaccine that prevents HIV infection should not only
induce functional inhibitory, neutralizing antibodies, but
also promote Fc-mediated inhibitory antibodies display-
ing ADCC or phagocytosis. The aim of this study is to
analyze the effect of IND02, a cinnamon derived procya-
nidin polymer on the interaction of HIV-1 gp120 with its
co-receptors as well as its adjuvant like activity along
with HIV-specific antibodies.
Methods
The ability of IND02 to interact with the HIV envelope
glycoprotein gp120 was analyzed by studying binding of
IND02 to gp120 envelopes by Biacore. The expressions of
FcgRs were evaluated on macrophages and NK primary
cells incubated with IND02 by flow cytometry. The inhibi-
tory activity of IND02 was assessed on PBMC using TZM-
bl assay for neutralization, Fc-mediated inhibitory activity
on macrophages and Antibody Dependant Cellular Cyto-
toxicity in presence or absence of anti-HIV antibodies.
Results
Binding of IND-02 to gp120 envelopes was dose-depen-
dent within the μM range and was capable to inhibit
gp120-CD4 interaction. A moderate decrease in the
expression of FcgR I and III was observed on macro-
phages treated with IND02, while FcgR II expression
was unaffected. FcgRIII expression on NK cells was not
modified. IND02 demonstrated low inhibitory activity
on TZMbL and PBMC, but was able to efficiently inhi-
bit HIV infection on macrophages. Moreover IND02
demonstrated synergistic effect when combined with
monoclonal inhibitory antibodies. An enhanced ADCC
was detected in presence of IND02 and anti-HIV speci-
fic antibodies.
Conclusion
IND02 represents an interesting class of botanical mole-
cule that binds to HIV-1 envelope protein, including the
co receptor binding site, impairing HIV interaction with
co-receptors on target cells. This interaction could
explain the decreased HIV replication observed after
IND02 treatment. Besides, an augmentation in the activ-
ity of HIV-specific antibodies, involving ADCC and Fc-
mediated phagocytosis, was observed in presence of
IND02 supporting additional adjuvant mechanisms that
could enhance immune responses against HIV.
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